Results 51 to 60 of about 3,445 (173)

Prevention and Treatment of Hemorrhagic Cystitis [PDF]

open access: yes, 1997
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90047/1/j.1875-9114.1997.tb03745.x ...
West, Nina J.
core   +1 more source

Antifibrinolytics in liver surgery

open access: yesIndian Journal of Anaesthesia, 2010
Hyperfibrinolysis, a known complication of liver surgery and orthotopic liver transplantation (OLT), plays a significant role in blood loss. This fact justifies the use of antifibrinolytic drugs during these procedures.
Jalpa Makwana   +2 more
doaj   +1 more source

Enabling icIEF Peak Identification of AAV Capsid Proteins by Fractionation on MauriceFlex and Subsequent Analysis by LC–MS

open access: yesELECTROPHORESIS, Volume 46, Issue 1-2, Page 22-33, January 2025.
ABSTRACT A significant limitation of imaged capillary electric focusing (icIEF) is the inability to identify and characterize specific species in the electropherogram. This has led to the development of complementary ion‐exchange chromatography (IEX)‐based methods that are amenable to either fraction collection and subsequent characterization or online
Will McElroy   +8 more
wiley   +1 more source

Perioperative use of Epsilon-aminocaproic acid in patients with the diagnosis of prostatic benign hyperplasia

open access: yesRevista Cubana de Anestesiología y Reanimación, 2016
Introduction: To reduce intraoperative blood loss and the use of transfusion requirements, antifibrinolytic agents that repermeabilize a bleeding vessel are used.
Zaily Fuentes Díaz   +2 more
doaj   +2 more sources

Evaluation of Methods Employed in Establishing Preclinical Similarity of Adalimumab Biosimilars

open access: yesAdvances in Pharmacological and Pharmaceutical Sciences, Volume 2025, Issue 1, 2025.
Adalimumab, marketed as Humira, is a fully humanized monoclonal antibody that blocks the activity of tumor necrosis factor‐alpha and is used in treating several autoimmune disorders. As one of the top‐grossing pharmaceuticals, its global sales surpassed $20 billion in 2023, leading to significant biosimilar development, with 10 products available by ...
Ramya Nair   +4 more
wiley   +1 more source

Treatment of Melasma With Q‐Switched Laser in Combination With Tranexamic Acid

open access: yesDermatology Research and Practice, Volume 2025, Issue 1, 2025.
Melasma, a pigmentary disorder that particularly affects Asian women, has been clinically proven to respond effectively to combination therapy of Q‐switched lasers and tranexamic acid (TXA), especially with the advancements in laser aesthetics in recent years. However, treatment outcomes can be influenced by factors such as the wavelength and spot size
Zirui Liu, Enzo Errichetti
wiley   +1 more source

Hereditary angioedema in pregnancy and management without recombinant human C1-INH [PDF]

open access: yes, 2021
A pregnant woman diagnosed with type 1 angioedema seeks care at a public hospital for planning the delivery. This report presents ways to prevent and manage an acute HAE crisis during childbirth and early postpartum without the availability of first-line
Behenck, Gabrielle   +8 more
core  

Massive Bleeding as the First Clinical Manifestation of Metastatic Prostate Cancer due to Disseminated Intravascular Coagulation with Enhanced Fibrinolysis

open access: yesCase Reports in Hematology, 2016
Disseminated intravascular coagulation (DIC) is the most frequent coagulation disorder associated with metastatic prostate adenocarcinoma. However, DIC with enhanced fibrinolysis as an initial presentation of prostate cancer is extremely rare.
Mónica Palma Anselmo   +4 more
doaj   +1 more source

A study of the interaction between Helicobacter pylori and components of the human fibrinolytic system

open access: yesBrazilian Journal of Medical and Biological Research, 2000
The interaction of plasminogen, tissue plasminogen activator (t-PA) and urokinase with a clinical strain of Helicobacter pylori was studied. Plasminogen bound to the surface of H. pylori cells in a concentration-dependent manner and could be activated to
A. Yarzábal   +5 more
doaj   +1 more source

An Advanced Mechanically Active Osteoarthritis‐on‐Chip Model to Test Injectable Therapeutic Formulations: The SYN321 Case Study

open access: yesAdvanced Healthcare Materials, Volume 13, Issue 32, December 27, 2024.
The uBeat® MultiCompress platform offers a novel approach for studying injectable therapies on human osteoarthritic (OA) cartilage microtissues in a physiologically‐ and mechanically‐relevant environment. It can accommodate therapeutic formulations like SYN321, a promising diclofenac‐sodium hyaluronate conjugate for knee OA treatment.
Cecilia Palma   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy